Pfizer. Mun bincika kamfanin don mai saka jari na dogon lokaci

PFIME INC (NYSE: PFE)

Daya daga cikin manyan kamfanoni na duniya. Kuma, ba shakka, sananniyar mai haɓaka ta ɗayan allurar daga magungunan daga coronavirus. Ra'ayoyin hannun jari a lokacin rubuta labaran: $ 36.50. A halin yanzu babban birni: $ 2033MLD. Za'a fitar da rahoton shekara-shekara a ranar 2 ga Fabrairu, 2021.

Tarihi

Tarihin kamfanin ya fara ne tare da Amurkawa 25 na shekaru 25 na farko, wanda a cikin 1849 a kan dala miliyan 2500 da tsofaffi ya bude wani karamin kamfanin magunguna. A cikin 1880, kamfanin ya fara fito da citric acid, saboda wanda ya kasance mai arziki sosai. Ee, a kan citric acid - an yi amfani dashi don samar da coca-cola (Nyse: ko) da Pepsi (nasdaQ: Pep). A lokacin yakin duniya na II, Pfizer ya sami damar fara samar da penillinlin, kamfanin ya zama mafi girman masana'antar wannan masana'antar duniya. Wa ya sani, watakila, a cikin shekara 50 game da Pfiher zai rubuta cewa wannan kamfani ya ce duniya daga CVID-19.

Af, a cikin 2016, kamfanin ya fara hadin gwiwa tare da IBM (Nyse: Ibm) (Maimaita wanda ya kasance a cikin rubutun da na gabata) akan daftarin amfani da na wucin gadi a cikin ci gaban kayan tarihi Gaskiya ne, a cikin 2019 IBM ta daina tallafawa aikin saboda ƙarancin riba.

Rarraba

A farkon kwata na 2021, kamfanin ya ɗaga ya fito da biyan kashi a shekara ta 12 a cikin jere, I.e. Ba wani rabo ne na Aristocrat. Amma kafin shekarar 2009, duk da haka, an tilasta shi yayin rikicin don rage rarrabuwa sau biyu. Rahoton Rarraba kan shafin yanar gizon kamfanin ne tun 1980, duk da cewa an san cewa Pfiiz ya karu da biyan kudi shekara-shekara daga 1973 zuwa 2009, kamfanin ya biya $ 1.56 a shekara ta shekara, ko 4.3% na shekara. Matsakaicin darajar biyan kuɗi zuwa masu hannun jarin daga ribar da ya gabata ~ 70%. Yawan rarraba daga 2009 akan matsakaita 6.5% a shekara (ko + 120%).

Canza darajar hannun jari

A shekara ta 2009, lokacin da ake tsammani na dogon lokaci ya ƙare, ya fara tambaya, wanda ya ci gaba har zuwa shekara ta 20. A kan canza darajar hannun jari, mai nasara mai saka jari zai iya samun kashi 300 a cikin ganiya! Idan, fara daga kowane lokaci daga 2011, da adadin farko na kowane wata na Pfiizer akan 1 Cu Kudin, yau matsakaicin farashin siye zai zama 90% na zaɓuɓɓukan da ke ƙasa da ambato na yanzu. Wadancan. Zuba jari a hannun jari na Pfiizer a cikin shekaru 10 da suka gabata, kusan duk wani mai saka jari wanda ya sami matsayi zai kawo riba (har zuwa 28%). Amma har yanzu raba rarrabuwa.

PFE wata-wata.

Alamomin hada kudi

Hadarin kudi guda biyu suna matsawa ne a kan kamfanonin masana'antu: ƙarshen lokacin mallakar kwayoyi da ikirarin shari'a daban-daban na magani. Dangane da kimantawa daban-daban, kudaden shiga na Pfil daga aiwatar da maganin COVID-19 na iya kaiwa daga 2 zuwa biliyan 4% na shekara-shekara). Tasirin kuɗi na kuɗi na dogon lokaci na allurar rigakafin alurar riga kafi ne, ko alurar riga kafi dole ne su zama tilas, ko kwayar cutar za ta bar mu har abada - ba a sani ba.

• Kudin PFIHER ya tabbata ga shekaru da yawa (kusan $ 50mld);
• Riba net ya karu daga dala biliyan 7 a cikin 2015 zuwa dala biliyan 16 a shekarar 2019 (amma a fili, riba ta 2020 ~ dala miliyan 11);
• Bashin tun shekarar 2018 ta girma da kashi 50% (daga dala biliyan 42 zuwa dala biliyan 63 An danganta shi da raguwa a cikin adalci).

Gabaɗaya, Pfizer ya cika alamomi gaba ɗaya masu dorewa.

Binciken Fasaha

Tun shekara ta 2009, maganganu suna da matsala sama kuma sun koma tashar shekaru 10. Lokacin da kasuwa faduwa a watan Fabrairu - Maris 2020, kwatancen ya tsaya a kan tallafi $ 27, bayan wannan tsayinsa ya fara a cikin sabuwar tashar. A halin yanzu, farashin yana zuwa ƙarshen iyakar tashar ta tashi. Tallafin sati na mako shine $ 32, juriya shine $ 37.5 da $ 42.5, da kuma babban "na tunani" shine $ 46.5 (matakin tashin hankali a cikin 1999-2000). Saboda gaskiyar cewa daga matsakaicin 2018, $ 44 Akwai digo zuwa $ 26.5, kuma bayan fitowar ta kasance kawai $ 43, an canza yanayin kawai zuwa ƙasa.

Pfe sati

Tsarin Zuba Jari

A shekarar 2020, duk duniya ta zama mafi mahimmanci game da lafiyarsa, an ba da izininsa babban rabo wanda ya kamata rijiyar amfani da shi. Yana da daraja siyan tallafi a jira na iyakar sabuntawa. Kyakkyawan matakin rabo na yawan amfanin ƙasa zai santsi jiran sabuntawa. Amma yana da mahimmanci a lura da amsawar ga tsayayya, tunda yanayin gaba mai yiwuwa ne.

Karanta abubuwan asali na asali akan: zuba jari.com